Siegel JJ, Prasai A, Farberg AS, Goldberg MS. Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC). J of Skin [Internet]. 2022Nov.16 [cited 2024Sep.20];6(6):s96. Available from: https://dermsquared.com/skin/article/view/1855